rAd-p53 Gene Therapy for Advanced Malignant Thyroid Tumors

NCT00902122 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Thyroid Tumors

Interventions

DRUG: rAd-p53 gene
PROCEDURE: surgery
DRUG: p53 gene therapy
RADIATION: p53 gene therapy with radioactive iodine

Sponsor

Shenzhen SiBiono GeneTech Co.,Ltd